openPR Logo
Press release

Global Acromegaly Market Insights, Forecast

04-22-2019 01:06 PM CET | Health & Medicine

Press release from: Market Density

Acromegaly is a hormonal disorder that develops when your pituitary gland produces too much growth hormone during adulthood. When this happens, your bones increase in size, including those of your hands, feet and face. Acromegalyusually affects middle-aged adults. The global Acromegaly market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Acromegaly market based on company, product type, end user and key regions. This report studies the global market size of Acromegaly in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Acromegaly in these regions. This research report categorizes the global Acromegaly market by top players/brands, region, type and end user. This report also studies the global Acromegaly market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. The following manufacturers are covered in this report, with sales, revenue, market share for each company: Novartis Aegis Therapeutics Chiasma Crinetics Pharmaceuticals Daewoong Pharmaceutical Peptron Silence Therapeutics Strongbridge Biopharma Amryt Pharma Foresee Pharmaceuticals Glide Pharmaceutical Ionis Pharmaceuticals Ipsen Market size by Product Somatostatin Analogues Dopamine Agonists Growth Hormone Receptor Antagonists Other Market size by End User Hospitals Clinics Market size by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global Acromegaly market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025. To understand the structure of Acromegaly market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Acromegaly companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development. To project the value and sales volume of Acromegaly submarkets, with respect to key regions. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. In this study, the years considered to estimate the market size of Acromegaly are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Acromegaly market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Get sample copy of the report:

https://www.marketdensity.com/contact?ref=Sample&reportid=121326

Table of Contents:

Table of Contents

1 Study Coverage
1.1 Acromegaly Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Acromegaly Market Size Growth Rate by Product
1.4.2 Somatostatin Analogues
1.4.3 Dopamine Agonists
1.4.4 Growth Hormone Receptor Antagonists
1.4.5 Other
1.5 Market by End User
1.5.1 Global Acromegaly Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Acromegaly Market Size
2.1.1 Global Acromegaly Revenue 2014-2025
2.1.2 Global Acromegaly Sales 2014-2025
2.2 Acromegaly Growth Rate by Regions
2.2.1 Global Acromegaly Sales by Regions
2.2.2 Global Acromegaly Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Acromegaly Sales by Manufacturers
3.1.1 Acromegaly Sales by Manufacturers
3.1.2 Acromegaly Sales Market Share by Manufacturers
3.1.3 Global Acromegaly Market Concentration Ratio (CR5 and HHI)
3.2 Acromegaly Revenue by Manufacturers
3.2.1 Acromegaly Revenue by Manufacturers (2014-2019)
3.2.2 Acromegaly Revenue Share by Manufacturers (2014-2019)
3.3 Acromegaly Price by Manufacturers
3.4 Acromegaly Manufacturing Base Distribution, Product Types
3.4.1 Acromegaly Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Acromegaly Product Type
3.4.3 Date of International Manufacturers Enter into Acromegaly Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Acromegaly Sales by Product
4.2 Global Acromegaly Revenue by Product
4.3 Acromegaly Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Acromegaly Breakdown Data by End User

6 North America
6.1 North America Acromegaly by Countries
6.1.1 North America Acromegaly Sales by Countries
6.1.2 North America Acromegaly Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Acromegaly by Product
6.3 North America Acromegaly by End User

7 Europe
7.1 Europe Acromegaly by Countries
7.1.1 Europe Acromegaly Sales by Countries
7.1.2 Europe Acromegaly Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Acromegaly by Product
7.3 Europe Acromegaly by End User

8 Asia Pacific
8.1 Asia Pacific Acromegaly by Countries
8.1.1 Asia Pacific Acromegaly Sales by Countries
8.1.2 Asia Pacific Acromegaly Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Acromegaly by Product
8.3 Asia Pacific Acromegaly by End User

9 Central & South America
9.1 Central & South America Acromegaly by Countries
9.1.1 Central & South America Acromegaly Sales by Countries
9.1.2 Central & South America Acromegaly Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Acromegaly by Product
9.3 Central & South America Acromegaly by End User

10 Middle East and Africa
10.1 Middle East and Africa Acromegaly by Countries
10.1.1 Middle East and Africa Acromegaly Sales by Countries
10.1.2 Middle East and Africa Acromegaly Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Acromegaly by Product
10.3 Middle East and Africa Acromegaly by End User

11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Company Business Overview
11.1.3 Novartis Acromegaly Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Novartis Acromegaly Products Offered
11.1.5 Novartis Recent Development
11.2 Aegis Therapeutics
11.2.1 Aegis Therapeutics Company Details
11.2.2 Company Business Overview
11.2.3 Aegis Therapeutics Acromegaly Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Aegis Therapeutics Acromegaly Products Offered
11.2.5 Aegis Therapeutics Recent Development
11.3 Chiasma
11.3.1 Chiasma Company Details
11.3.2 Company Business Overview
11.3.Chiasma Acromegaly Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Chiasma Acromegaly Products Offered
11.3.5 Chiasma Recent Development
11.4 Crinetics Pharmaceuticals
11.4.1 Crinetics Pharmaceuticals Company Details
11.4.2 Company Business Overview
11.4.3 Crinetics Pharmaceuticals Acromegaly Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Crinetics Pharmaceuticals Acromegaly Products Offered
11.4.5 Crinetics Pharmaceuticals Recent Development
11.5 Daewoong Pharmaceutical
11.5.1 Daewoong Pharmaceutical Company Details
11.5.2 Company Business Overview
11.5.3 Daewoong Pharmaceutical Acromegaly Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Daewoong Pharmaceutical Acromegaly Products Offered
11.5.5 Daewoong Pharmaceutical Recent Development
11.6 Peptron
11.6.1 Peptron Company Details
11.6.2 Company Business Overview
11.6.3 Peptron Acromegaly Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Peptron Acromegaly Products Offered
11.6.5 Peptron Recent Development
11.7 Silence Therapeutics
11.7.1 Silence Therapeutics Company Details
11.7.2 Company Business Overview
11.7.3 Silence Therapeutics Acromegaly Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Silence Therapeutics Acromegaly Products Offered
11.7.5 Silence Therapeutics Recent Development
11.8 Strongbridge Biopharma
11.8.1 Strongbridge Biopharma Company Details
11.8.2 Company Business Overview
11.8.3 Strongbridge Biopharma Acromegaly Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Strongbridge Biopharma Acromegaly Products Offered
11.8.5 Strongbridge Biopharma Recent Development
11.9 Amryt Pharma
11.9.1 Amryt Pharma Company Details
11.9.2 Company Business Overview
11.9.3 Amryt Pharma Acromegaly Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Amryt Pharma Acromegaly Products Offered
11.9.5 Amryt Pharma Recent Development
11.10 Foresee Pharmaceuticals
11.10.1 Foresee Pharmaceuticals Company Details
11.10.2 Company Business Overview
11.10.3 Foresee Pharmaceuticals Acromegaly Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Foresee Pharmaceuticals Acromegaly Products Offered
11.10.5 Foresee Pharmaceuticals Recent Development
11.11 Glide Pharmaceutical
11.12 Ionis Pharmaceuticals
11.13 Ipsen

12 Future Forecast
12.1 Acromegaly Market Forecast by Regions
12.1.1 Global Acromegaly Sales Forecast by Regions 2019-2025
12.1.2 Global Acromegaly Revenue Forecast by Regions 2019-2025
12.2 Acromegaly Market Forecast by Product
12.2.1 Global Acromegaly Sales Forecast by Product 2019-2025
12.2.2 Global Acromegaly Revenue Forecast by Product 2019-2025
12.3 Acromegaly Market Forecast by End User
12.4 North America Acromegaly Forecast
12.5 Europe Acromegaly Forecast
12.6 Asia Pacific Acromegaly Forecast
12.7 Central & South America Acromegaly Forecast
12.8 Middle East and Africa Acromegaly Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Acromegaly Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Browse this report online:

https://www.marketdensity.com/global-acromegaly-market-insights-forecast

About Market Density:

Market Density is your one stop market research and industry analysis reports' library providing business data and intelligence information on thousands of micro markets with global as well as regional coverage.
Market Density offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Market Density understands how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:

Email: sales@marketdensity.com

Website: www.marketdensity.com

Phone: +1 669 264 1656

4340 Stevens Creek Blvd,, Suite # 172,, San Jose, CA 95129

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Acromegaly Market Insights, Forecast here

News-ID: 1712513 • Views: 230

More Releases from Market Density

Global Product Management Software Market Size, Status and Forecast
This report focuses on the global Product Management Software status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Product Management Software development in United States, Europe and China. In 2017, the global Product Management Software market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. The key players
Global Computer Aided Engineering (CAE) Market Size, Status and Forecast
This report focuses on the global Computer Aided Engineering (CAE) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Computer Aided Engineering (CAE) development in United States, Europe and China. Computer-aided engineering is the broad usage of computer software to aid in engineering analysis tasks. In regard to information networks, CAE systems are individually considered a single node on a total information
Global Computerized Numerical Control Market Size, Status and Forecast
This report focuses on the global Computerized Numerical Control status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Computerized Numerical Control development in United States, Europe and China. Computer numerical control (CNC) is the automation of machine tools by means of computers executing pre-programmed sequences of machine control commands. The key factor contributing to the computerized numerical control market is the growth
Global Connected Retail Market Size, Status and Forecast
This report focuses on the global Connected Retail status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Connected Retail development in United States, Europe and China. A Connected Retail strategy allows people to use the strength of the network to connect the brands to today's consumers. Connected Retail can help collaborate more effectively with employees and field managers, maintain security vigilance and

All 5 Releases


More Releases for Acromegaly

Acromegaly Treatment Market Opportunity Analysis, 2018-2026
Acromegaly is a rare disorder caused due to the excess production of growth hormone by the pituitary gland, affecting a patient’s physical appearance and internal organs. It is usually caused by benign pituitary tumor (adenoma), however, in rare cases acromegaly symptoms can be observed due to ineffective control of growth hormone-secreting cells by hypothalamus. Abnormal enlargement of hands, arms, feet, legs, and head, and gradual changes in facial features such
Acromegaly Treatment Market Key Factors And Growth Forecast 2017 – 2025
Acromegaly is a rare disorder caused due to the excess production of growth hormone by the pituitary gland, affecting a patient’s physical appearance and internal organs. It is usually caused by benign pituitary tumor (adenoma), however, in rare cases acromegaly symptoms can be observed due to ineffective control of growth hormone-secreting cells by hypothalamus. Abnormal enlargement of hands, arms, feet, legs, and head, and gradual changes in facial features such
Global Acromegaly Treatment Market (Ectopic Acromegaly & Pseudo Acromegaly)Diagn …
Global acromegaly treatment market was valued at approximately USD +664.0 Million in 2016 and is expected to generate revenue of around USD +838.0 Million by the end of 2022, growing at a CAGR of around +3.94% between 2017 and 2022. There are various symptoms experienced by the patient like the protruded jaw, increased the size of limbs, the spacing between teeth of lower jaw and others. Conditions like hypertension, diabetes,
Global Acromegaly Market Research Report 2017
Global Acromegaly market value is provided for 2016 in million-dollar offered by the end of 2022, shows a consistent growth between 2016 and 2022. In this report, the global Acromegaly market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request a Free sample PDF of this research to
Global Acromegaly Market Pipeline Review, H2 2017
"The Report Acromegaly - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acromegaly - Pipeline Review, H2 2017, provides an overview of the Acromegaly (Hormonal Disorders) pipeline landscape. Acromegaly is a hormonal disorder that develops when pituitary gland produces too much growth hormone during adulthood. Symptoms include body odor,
Acromegaly and Gigantism Market: Opportunity Analysis and Forecast to 2018
"The Report OpportunityAnalyzer: Acromegaly and Gigantism - Opportunity Analysis and Forecast to 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Acromegaly and Gigantism Market GlobalData estimates the 2013 sales for acromegaly and gigantism at approximately $588m across the 6MM covered in this report. The market will grow moderately at a CAGR of 3.74% during the five year forecast period, generating sales